PLAU and lipoprotein glomerulopathy: In a primary glomerulopathy study, the urinary uPA levels were significantly reduced by intraglomerular fibrin deposition, which suggests that a decrease in urinary uPA levels and diminution of isolated intraglomerular plasminogen activator activity contribute to disease progression [14].